These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37129468)

  • 1. Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic.
    Nascimento de Lima P; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
    Elife; 2023 May; 12():. PubMed ID: 37129468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis.
    de Lima PN; van den Puttelaar R; Hahn AI; Harlass M; Collier N; Ozik J; Zauber AG; Lansdorp-Vogelaar I; Rutter CM
    medRxiv; 2022 Dec; ():. PubMed ID: 36597528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When History and Heterogeneity Matter: A Tutorial on the Impact of Markov Model Specifications in the Context of Colorectal Cancer Screening.
    Townsley RM; Koutouan PR; Mayorga ME; Mills SD; Davis MM; Hasmiller Lich K
    Med Decis Making; 2022 Oct; 42(7):845-860. PubMed ID: 35543440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Landscape Assessment of Colorectal Cancer Screening during the COVID-19 Pandemic.
    El Bizri M; Hamidi MW; Mksyartinian P; Stein BD
    Curr Oncol; 2023 Oct; 30(10):8973-8991. PubMed ID: 37887548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and Recovery from COVID-19-Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis.
    van den Puttelaar R; Lansdorp-Vogelaar I; Hahn AI; Rutter CM; Levin TR; Zauber AG; Meester RGS
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):22-29. PubMed ID: 36215205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.
    Worthington J; van Wifferen F; Sun Z; de Jonge L; Lew JB; Greuter MJE; van den Puttelaar R; Feletto E; Lansdorp-Vogelaar I; Coupé VMH; Ein Yong JH; Canfell K;
    EClinicalMedicine; 2023 Aug; 62():102081. PubMed ID: 37538541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study.
    Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T
    Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    de Jonge L; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; Spaander MCW; van Vuuren HJ; van Kemenade FJ; Dekker E; Nagtegaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    PLoS One; 2022; 17(6):e0270223. PubMed ID: 35749423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic disparities in colon cancer screening and adherence during the COVID-19 pandemic: a retrospective cohort analysis.
    Nwankwo EC; Hendrix C; Pollard K; Kallal C; Cruschiel T; Buckhold F; Hachem C
    Int J Colorectal Dis; 2022 Apr; 37(4):849-854. PubMed ID: 35275279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review.
    Mazidimoradi A; Tiznobaik A; Salehiniya H
    J Gastrointest Cancer; 2022 Sep; 53(3):730-744. PubMed ID: 34406626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Évaluation de la gravité du cancer colorectal dépisté dans le contexte de la crise sanitaire liée au COVID19 en région Ile-de-France].
    Koïvogui A; Abihsera G; Le Trong T; Ait-Hadad H; Bernoux A; Delattre H; Vincelet C; Caroll R; Nicolet J
    Rev Epidemiol Sante Publique; 2023 Oct; 71(5):102124. PubMed ID: 37451076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation.
    Hijos-Mallada G; Alfaro E; Navarro M; Cañamares P; Ariño I; Charro M; Bruno C; Solano M; Pardillos A; Jimeno C; Carrera-Lasfuentes P; Lanas A; Domper-Arnal MJ
    Gastroenterol Hepatol; 2023 Nov; 46(9):702-709. PubMed ID: 36716926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening.
    Jen GH; Yen AM; Hsu CY; Chiu HM; Chen SL; Chen TH
    Prev Med; 2021 Oct; 151():106597. PubMed ID: 34217416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase.
    Choy AM; Lebwohl B; Krigel A
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):739-743. PubMed ID: 35102113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic.
    Bright D; Hillier S; Song J; Huws DW; Greene G; Hodgson K; Akbari A; Griffiths R; Davies AR; Gjini A
    BMC Public Health; 2023 Mar; 23(1):546. PubMed ID: 36949447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.